PHILADELPHIA, Nov. 11, 2008 (GLOBE NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, announced today that it is scheduled to present at the upcoming Lazard Capital Markets 5th Annual Healthcare Conference in New York on Tuesday, November 18, 2008. Gearoid Faherty, Chairman and Chief Executive Officer of Eurand, will be presenting.
Event: Lazard Capital Markets 5th Annual Healthcare Conference Date: Tuesday, November 18, 2008 Time: 1:10 p.m. ET Location: The St. Regis New York
An audio webcast of the presentation will be available by accessing the investor relations section of Eurand's web site at www.eurand.com. A replay of the presentation will be available until December 18, 2008.
About Eurand
Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. Eurand has had four products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Eurand's technology platforms include bioavailability enhancement of poorly soluble drugs, customized release, taste-masking/fast-dissolving formulations and drug conjugation.
Eurand is a global company with facilities in the U.S. and Europe. For more information, visit Eurand's website at www.eurand.com.